Purvalanol A (Standard)
Purvalanol A (Standard) is the analytical standard of Purvalanol A. This product is intended for research and analytical applications. Purvalanol A is a potent CDK inhibitor, which inhibits cdc2-cyclin B, cdk2-cyclin A, cdk2-cyclin E, cdk4-cyclin D1, and cdk5-p35 with IC50s of 4, 70, 35, 850, 75 nM, resepctively.
Product Specifications
CAS Number
212844-53-6
UNSPSC
12352100
Target
Apoptosis; Autophagy; CDK; Reference Standards
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Others
Field of Research
Cancer
Smiles
CC([C@@H](NC1=NC(NC2=CC=CC(Cl)=C2)=C3N=CN(C(C)C)C3=N1)CO)C
Molecular Formula
C19H25ClN6O
Molecular Weight
388.89
References & Citations
[1]Gray NS, et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 1998 Jul 24;281 (5376) :533-8.|[2]Bain J, et al. The specificities of protein kinase inhibitors: an update. Biochem J. 2003 Apr 1;371 (Pt 1) :199-204.|[3]Villerbu N, et al. Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities. Int J Cancer. 2002 Feb 20;97 (6) :761-9.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683240-100 1x 100 µL
Serum Amyloid P / APCS (APCS/3240), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB2876-100 1x 100 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (C31/2876R), 0.2mg/mL
Sign In for Pricing
View Details 